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Objective: To investigate analgesia using lidocaine suppository for prostate biopsy. 
 
Material and methods: From 2007 to 2009, 160 patients underwent the trans-rectal ultrasound 
guided prostate biopsy at the Department of Urology, KBC Zagreb. Eighty patients received 
60 mg lidocaine suppository intra-rectally at different time points from 15 to 120 minutes 
before biopsy and 80 patients received glycerine suppository as placebo. We also collected 
data about patient age, prostate specific antigen levels, prostate volume and pathohistological 
findings after the biopsy. The pain level was evaluated using a visual analogue scale (VAS). 
 
Results: There were no statistically significant differences between the groups i.e. they were 
similar regarding the patients’ age, prostate specific antigen levels, prostate volume and the 
incidence of diagnosis of malignancy on biopsy. The mean pain score in the lidocaine group 
(3 ± 1) was significantly lower than the mean pain score in the glycerine group (4.1 ± 1.3)  
[p< 0.001]. A noticeable trend towards lower pain scores in the lidocaine group was observed 
with more time elapsed from placing the suppository till the biopsy and the optimal time for 
performing the biopsy starts approximately one hour after placing the suppository. 
 
Conclusion: Lidocaine suppository is an easy to use, self applicable (by the patient) and cheap 
method of local analgesia, with acceptable results. Possible complications related to this 
procedure are insignificant. 
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Introduction 
 
Prostate biopsy is a standard method for establishing the diagnosis of prostate 
cancer and therefore one of the most commonly performed urological procedures. 
Although in the past this was considered to be a relatively well tolerated procedure 
and thus no analgesia was applied in the great majority of cases, patient-reported 
data have shown that 65%-90% of patients suffered discomfort during prostate 
biopsy and 30% of them had significant pain.(1,2) It has also been shown that almost 
19% of patients would refuse a repeated biopsy without some form of analgesia.(3) 
Different methods of analgesia for prostate biopsy have been investigated and 
among them periprostatic nerve block (PPNB) is considered as a gold standard. 
Recent meta-analyses have confirmed that PPNB is effective and safe in reducing 
pain caused by trans-rectal biopsy(4) but many urologists still did not perform it, 
probably because they are not comfortable with this procedure. 
 
In this study our objective was to investigate the analgesia effect of lidocaine 
suppository compared to glycerine suppository as placebo and optimal time of 
lidocaine application prior to biopsy. 
 
 
Material and methods 
 
From October 2007 to January 2009, 160 patients with abnormal digital rectal exam 
(DRE) or elevated prostate-specific antigen (PSA) values, or both, underwent 
transrectal ultrasound (TRUS) - guided biopsy at Department of Urology, KBC 
Zagreb, Croatia. The study was approved by the Institutional Review Board and each 
patient signed the informed consent. Exclusion criteria were: allergy to local 
anaesthetic, rectoanal pathology, chronic prostatitis, chronic pelvic pain, urge urinary 
symptoms, hemorrhagic diathesis, anticoagulation therapy, renal and hepatic 
insufficiency. We also excluded patients with a history of daily analgesic use which 
could influence their pain perception. This was a double blind study and patients 
were randomized in two groups. Group L (80 patients) received 60 mg lidocaine 
suppository (Lido-posterine suppositories, Dr. Kade Pharm, Berlin, Germany) intra-
rectally at different time points from 15 to 120 minutes before biopsy, while group G 
(80 patients) received glycerine suppository in the same way. All patients received 
intra-rectal lubricant jelly before DRE and probe insertion. Prophylaxis was carried 
out by the oral administration of 500 mg of ciprofloxacin a few hours before the 
biopsy and followed twice a day for five days in total. A cleaning enema was self-
administered on the morning of the biopsy. The biopsy was taken with the patient in 
the prone (jack-knife) position by urologists experienced in undertaking of this 
procedure. The biopsy was taken under TRUS guidance using a 7.5 MHz trans-rectal 
probe (Sonoline X, Siemens, Berlin, Germany). Before the procedure, the prostate 
gland volume was determined and in all cases 12 core biopsy samples were taken, 
using automatic spring-loaded biopsy gun (Magnum, Bard, New Jersey, USA) with 18 
gauge, 25 cm needle. A self-administrated 10-point visual analogue scale (VAS) was 
used to measure the pain scores before and immediately after the biopsy. 
 
Before the procedure, all patients were instructed by the physician to score their level 
of pain from 0 (no pain) to 10 (most severe pain ever experienced) on the VAS. 
Patients with a baseline VAS score greater than 0 were excluded from the study. 
After the biopsy, the patients were informed about possible complications, such as 
fever, urinary retention, rectal bleeding, gross haematuria or hypotension. All patients 
were observed for an hour after the procedure to rule out possible early 
complications and then discharged when ready and stable. 
 
Statistical analysis: the Kolmogorov-Smirnov test was used to describe data 
distribution. According to the distribution, appropriate nonparametric tests were used 
in the following analysis. Differences in quantitative variables between the lidocaine 
and the glycerol group were analyzed with the Mann-Whitney U test. Qualitative and 
categorical dana were analyzed with the X2 test. The ROC curve analysis was 
performed to assess the optimal time for inserting the lidocaine suppository. All P 
values <0.05 are considered significant. StatSoft, Inc. (2008) STATISTICA (data 
analysis software system), version 8.0. (www.statsoft.com) was used for all statistical 
procedures except the ROC curve analysis (MedCalc for Windows, v 11.01, 
www.medcalc.be). 
 
 
 
Results 
 
Of the 160 men, 80 were randomly selected to receive the lidocaine suppository 
intrarectally (group L) and 80 were randomly selected to receive placebo (glycerine 
suppository (group G). Table 1 shows the baseline characteristics of these two 
groups. There were no statistically significant differences between groups, i.e. they 
were similar regarding the patients’ age, PSA level, prostate volume and the 
incidence of diagnosis of malignancy on biopsy. The median (interquartile range) 
pain score in the L group: 3.0 (2.2 - 3.8) was significantly lower than the median pain 
score in the G group: 4.0 (3.2 - 4.8), p<0.001 (Fig.1). Both groups were divided into 
three different subgroups according to the time elapsed from suppository insertion till 
the biopsy. The first subgroup’s time category was 15-45 minutes, the second 45-90 
minutes, and the third >90 minutes. A noticeable trend towards lower pain scores in 
the L group was observed with more time elapsed from suppository insertion till the 
biopsy (Fig. 2). This was not found in the G group (Fig. 3).  
Analyzing the dana we found that the optimal time for performing the biopsy starts 
approximately one hour after the placement of suppository. There were no significant 
differences between the groups in minor complications, like mild rectal bleeding, mild 
haematuria and haemospermia. Five patients in the glycerine group and 3 patients in 
the lidocaine group had septic complications which resolved after treatment with IV 
antibiotics. No local or general adverse effects which could be related to the 
application of the anaesthetic have been observed. 
 
Discussion 
 
Lidocaine is widely used for different forms of local analgesia. For prostate biopsies 
the most commonly used form is gel, alone or in combination with other methods of 
analgesia. Trans-rectal application of lidocaine suppository for pain caused by 
anorectal pathology is common. Rectal mucosa has a high vascularisation with large 
absorption capacity and therefore rectal route can be suitable for delivering different 
drugs, including analgesic and local anaesthetics   
 
 
Lidocaine suppositories are rarely used for prostate biopsies. In fact, to the best of 
our knowledge only three studies using lidocaine suppositories for trans-rectal 
ultrasound guided biopsy have been published up till now and all of them are 
confirming the analgesic effect of lidocaine suppositories in prostate biopsy alone or 
in combination with PPNB which is considered as a gold standard.(5,6,7) In this study 
we have investigated the use of lidocaine suppository for prostate biopsy compared 
to glycerine suppository as placebo. Although previous studies used fixed time points 
(1h vs. 2h) (5,6,7) we were using different time points for the biopsy after administering 
lidocaine suppositories (from 15 min. to 2 hours) in order to see if we can get better 
results using wider time frame. We have shown that the optimal time for performing a 
prostate biopsy starts approximately one hour after placing the lidocaine suppository, 
with better results being achieved the longer the suppository is in place prior to the 
biopsy.  Similar findings have been shown in other studies, were better results have 
been achieved when biopsy was performed 2 hour after placing the suppository 
comparing to 1 hour. (5,6) 
 
Diclofenac can be used for prostate biopsy in the form of suppository as well. The 
advantage of diclofenac use is attributed to its locally and systematically 
antiinflammatory effect which can also reduce post-procedural pain.(8,9) It is also 
important to mention that there is a higher risk of trombocite dysfunction and related 
prolonged time of bleeding (rectal bleeding and haematuria) with the use of non-
steroid antiinflammatory drugs (NSAID).(8,9) On the other hand, according to a number 
of papers cited in a recent review by Cassuti et al. local anaesthetics also posses a 
wide range of anti-inflammatory actions which can be superior to traditional anti-
inflammatory agents of the NSAID and steroid groups with fewer side-effects.(10) It 
has also been shown that local anaesthetics have antimicrobial activity as well.(11) 
Some of them like lidocaine and bupivacaine exhibited higher degrees of 
antimicrobial activity which can be an important advantage for procedures such as 
prostate biopsy. According to the majority of papers and recently published meta-
analyses the best analgesia for prostate biopsy can be achieved by using the 
periprostatic nerve block (PPNB).(4) Although many centres have accepted this form 
of analgesia, there is still a significant number of urologist who are not using this 
procedure in their daily praxis.(12) Reasons for this vary, but it is likely that some of 
them are not familiar with the procedure itself, while others cite discomfort of patients 
due to puncture with the needle. Also, although one study has shown a significantly 
higher rate of bacteriuria in the PPNB patients, (13) the recent paper published by 
Turgut et al. which included 200 patients, showed that PPNB is not associated with 
increased risk of local and systemic infection.(14)  In some patients PPNB does not 
completely eliminate pain, especially related to insertion of ultrasound probe in the 
rectum. In fact, it may cause astinging sensation and can be even more painful than 
the prostate biopsy itself.(15)  
  
 
Research have shown that a combination of topical anesthesia before inserting the 
transrecetal probe and PPNB achieved better analgesia during the entire procedure 
than application of a PPNB alone (7, 16). The most likely reason for this are two origins 
of pain, one of the placing the transrectal probe and another because of multiple 
punctures of anterior wall of the prostatic capsule. (16)   The lack of our study is that 
we did not evaluate the pain scores separately for different parts of the procedure (for 
the biopsy itself and for placing the ultrasound probe). Some patients reported even 
more pain from placing the ultrasound probe in the rectum than from the biopsy itself. 
This finding has also been reported by other authors (17)  Szlauer R et al. showed in 
their last paper that addition of lidocaine  suppositories to PPNB improving analgesia 
in comparison to PPNB alone.(7) Our study did not include comparison with PPNB 
since it is not routinely performed at our institution. 
 
One of the most effective topical anesthetic is a eutectic mixture of lidocaine and  
prilocaine which applied perianally-intrarectally can be used for prostate biopsy. (18,19) 
In comparison with PPNB alone, combining the EMLA cream with PPNB is more 
effective in reducing pain during all phases of the prostate biopsy.(16) But EMLA 
demands a relatively long time from cream application till the probe insertion and 
biopsy and requires the involvement of medical personnel in the procedure itself, not 
to mention the cost of the cream which is not insignificant.(16) 
 
We have shown that with the application of lidocaine suppositories acceptable 
analgesic results can be achieved without any risk. Moreover, this is a simple and 
cheap form of analgesia which can be performed by the patient himself. The 
procedure can also be used alone or in combination with other methods of analgesia. 
We have also shown that the optimal time for performing a biopsy starts 
approximately one hour after the placement of the suppository. No statistically 
significant influence of different variables (patient age, PSA value and 
patohistological findings) which are important for patients going on prostate biopsy on 
VAS score have been found. 
 
Based on previous research, a combination of topical anesthetics and PPNB gives 
the best result, but for institution where PPNB is not routinely performed and the 
application of prilocain-lidocain cream is expensive and requires additional 
engagement of medical staff, lidocaine suppository may be acceptable form of 
analgesia. Lidocaine suppository is an easy to use, self applicable and cheap method 
of local analgesia with acceptable results. Possible complications related with this 
procedure are insignificant.  
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Table 1. Baseline patient characteristics in the lidocaine and glycerol groups. 
 
 
 
 
Figure 1. Median pain level of the lidocaine and glycerol groups. 
 
 
 
Figure 2. VAS score depending on the time of the placement of the suppository before 
the procedure in the lidocaine group, with the VAS score decreasing as more time 
elapses from the placement of the suppository till the biopsy.  
 
 
 
 
 
 
 
Figure 3. VAS score depending on the time of the placement of the suppository before 
the biopsy in the glycerol group, with no significant differences in VAS score being 
observed during the time elapsed from the placement of the suppository till the biopsy. 
 
 
 
